
Phase I trials target aggressive tumors in children
Avapritinib, an FDA-approved drug used to treat other types of cancer, also decreases aggressive gliomas in animal models and in an initial cohort of patients with high-grade glioma
Atypical Teratoid Rhabdoid Tumors are a fast-growing cancer of the brain and spine